Skip to main content
Caplight Logo









Allelica, Inc.

Allelica, Inc.

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://allelica.com/

Last Round

Seed

Mar 12, 2021

Total Funding Raised

$1.86M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Allelica, Inc. is a healthtech company that develops a genomic risk prediction platform designed to provide access to clinical-grade polygenic risk scores (PRS).

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Healthcare Analytics, Clinical Trials

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

polygenic risk scorePRSgenetic risk assessmentprecision medicinegenomic softwareclinical decision supportgenomicsclinical AIpopulation healthpredictive healthpreventative caregenomic data analysishealth techbiotech software

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Allelica, Inc. Comparables

Compare Allelica, Inc. with similar companies based on industry and business-model similarity.

Allelica, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
OpenDNA
86%
Galatea Bio Inc.
82%
Antegenes
80%

Allelica, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMar 12, 2021
GrantJun 2, 2020
GrantJul 15, 2019
Pre SeedMar 1, 2018

Key People

Founding team and executive leadership

Paolo Di Domenico

CTO & Co-Founder

Founding Team

Giordano Botta

CEO & Co-Founder

Founding Team

Allelica, Inc. Investors

Notable investors and investment history

Allelica, Inc. investors
InvestorRounds
Pi CampusSeed, Pre Seed
Valor VenturesSeed
EIT HealthGrant
Valor VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 20, 2026

    Monthly visitors grew 50% MoM, reaching 28.5K.

  • Apr 7, 2026

    Selected as PRS testing collaborator for Mass General Brigham's PROACT 3 trial.

Allelica, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Allelica, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Allelica, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range11
Year Founded2017
Last FundingMar 12, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?